These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4612885)

  • 1. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Steroids and cyclophosphamide dosage in renal allograft perfusion.
    Woods JE; Zincke H
    Transplantation; 1976 Mar; 21(3):260. PubMed ID: 781925
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of high dose steroid and cyclophosphamide on perfused canine renal homografts.
    Tremann JA; Haines JG; Bleifuss JH; Agodoa LC; Marchioro TL
    Transplantation; 1975 Jun; 19(6):520-2. PubMed ID: 1094642
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Fitzpatrick HF
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of renal allograft rejection with intravenous methylprednisolone "pulse" therapy.
    Feduska NJ; Turcotte JG; Gikas PW; Bacon GE; Penner JA
    J Surg Res; 1972 Mar; 12(3):208-15. PubMed ID: 4553523
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.